207 related articles for article (PubMed ID: 27991598)
1. Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles.
Hsieh YC; Cheng TC; Wang HE; Li JJ; Lin WW; Huang CC; Chuang CH; Wang YT; Wang JY; Roffler SR; Chuang KH; Cheng TL
Sci Rep; 2016 Dec; 6():39119. PubMed ID: 27991598
[TBL] [Abstract][Full Text] [Related]
2. Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules.
Lin WW; Hsieh YC; Cheng YA; Chuang KH; Huang CC; Chuang CH; Chen IJ; Cheng KW; Lu YC; Cheng TC; Wang YT; Roffler SR; Cheng TL
Anal Chem; 2016 Dec; 88(24):12371-12379. PubMed ID: 28193011
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of PEGylated interferon detection by anti-polyethylene glycol (PEG) antibodies depends on PEG length.
Cheng TC; Chuang KH; Chen M; Wang HE; Tzou SC; Su YC; Chuang CH; Kao CH; Chen BM; Chang LS; Roffler SR; Cheng TL
Bioconjug Chem; 2013 Aug; 24(8):1408-13. PubMed ID: 23837865
[TBL] [Abstract][Full Text] [Related]
4. Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies.
Su YC; Chen BM; Chuang KH; Cheng TL; Roffler SR
Bioconjug Chem; 2010 Jul; 21(7):1264-70. PubMed ID: 20536171
[TBL] [Abstract][Full Text] [Related]
5. Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA.
Chuang KH; Tzou SC; Cheng TC; Kao CH; Tseng WL; Shiea J; Liao KW; Wang YM; Chang YC; Huang BJ; Wu CJ; Chu PY; Roffler SR; Cheng TL
Anal Chem; 2010 Mar; 82(6):2355-62. PubMed ID: 20178318
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles.
Cheng TL; Cheng CM; Chen BM; Tsao DA; Chuang KH; Hsiao SW; Lin YH; Roffler SR
Bioconjug Chem; 2005; 16(5):1225-31. PubMed ID: 16173802
[TBL] [Abstract][Full Text] [Related]
7. Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules.
Lin WW; Cheng YA; Kao CH; Roffler SR; Lee YC; Chen BM; Hsieh YC; Chen IJ; Huang BC; Wang YT; Tung YC; Huang MY; Chen FM; Cheng TL
Anal Chem; 2017 Jun; 89(11):6082-6090. PubMed ID: 28485140
[TBL] [Abstract][Full Text] [Related]
8. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent.
Fahrländer E; Schelhaas S; Jacobs AH; Langer K
Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544
[TBL] [Abstract][Full Text] [Related]
9. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
10. Analytical measurement of PEGylated molecules.
Cheng TL; Chuang KH; Chen BM; Roffler SR
Bioconjug Chem; 2012 May; 23(5):881-99. PubMed ID: 22242549
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
12. MS
Yin L; Su C; Ren T; Meng X; Shi M; Paul Fawcett J; Zhang M; Hu W; Gu J
Analyst; 2017 Nov; 142(22):4279-4288. PubMed ID: 29022970
[TBL] [Abstract][Full Text] [Related]
13. Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid Antibodies.
Tung HY; Su YC; Chen BM; Burnouf PA; Huang WC; Chuang KH; Yan YT; Cheng TL; Roffler SR
Mol Cancer Ther; 2015 Jun; 14(6):1317-26. PubMed ID: 25852063
[TBL] [Abstract][Full Text] [Related]
14. Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance.
Shiraishi K; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Sanada Y; Mochizuki S; Sakurai K; Yokoyama M
J Control Release; 2016 Jul; 234():59-67. PubMed ID: 27164541
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against polyethylene glycol in human blood: A literature review.
Hong L; Wang Z; Wei X; Shi J; Li C
J Pharmacol Toxicol Methods; 2020; 102():106678. PubMed ID: 31981619
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines.
Chen WA; Chang DY; Chen BM; Lin YC; Barenholz Y; Roffler SR
ACS Nano; 2023 Mar; 17(6):5757-5772. PubMed ID: 36926834
[TBL] [Abstract][Full Text] [Related]
17. Polyethylene glycol (PEG) as a broad applicability marker for LC-MS/MS-based biodistribution analysis of nanomedicines.
Hyldbakk A; Hansen T; Hak S; Borgos SEF
J Control Release; 2024 Feb; 366():611-620. PubMed ID: 38215988
[TBL] [Abstract][Full Text] [Related]
18. Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo.
Grenier P; Viana IMO; Lima EM; Bertrand N
J Control Release; 2018 Oct; 287():121-131. PubMed ID: 30138715
[TBL] [Abstract][Full Text] [Related]
19. Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture.
Lin YC; Chen BM; Tran TTM; Chang TC; Al-Qaisi TS; Roffler SR
J Control Release; 2023 Feb; 354():354-367. PubMed ID: 36641121
[TBL] [Abstract][Full Text] [Related]
20. A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers.
Liu Y; Reidler H; Pan J; Milunic D; Qin D; Chen D; Vallejo YR; Yin R
J Pharmacol Toxicol Methods; 2011; 64(3):238-45. PubMed ID: 21827863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
